TBPH
Theravance Biopharma Inc

1,026
Mkt Cap
$1.04B
Volume
77.00
52W High
$21.03
52W Low
$7.90
PE Ratio
36.41
TBPH Fundamentals
Price
$20.48
Prev Close
$19.58
Open
$19.57
50D MA
$19.10
Beta
0.53
Avg. Volume
381,994.50
EPS (Annual)
-$1.16
P/B
4.46
Rev/Employee
$663,721.65
Loading...
Loading...
News
all
press releases
Theravance Biopharma's (TBPH) "Buy" Rating Reaffirmed at BTIG Research
BTIG Research reaffirmed a "buy" rating and issued a $40.00 price target on shares of Theravance Biopharma in a research note on Tuesday...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Noteworthy Wednesday Option Activity: TBPH, APH, LQDA
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Theravance Biopharma, Inc. (Symbol: TBPH), where a total of 2,009 contracts have traded so...
Nasdaq News: Markets·12d ago
News Placeholder
Is the Options Market Predicting a Spike in Theravance Biopharma Stock?
Investors need to pay close attention to TBPH stock based on the movements in the options market lately.
Zacks·12d ago
News Placeholder
Why Theravance Biopharma (TBPH) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·17d ago
News Placeholder
Theravance Biopharma (NASDAQ:TBPH) Reaches New 1-Year High - Here's What Happened
Theravance Biopharma (NASDAQ:TBPH) Hits New 52-Week High - What's Next...
MarketBeat·19d ago
News Placeholder
Why Theravance Biopharma (TBPH) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·25d ago
News Placeholder
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Recommendation of "Buy" by Analysts
Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH - Get Free Report) have earned an average rating of "Buy" from the seven research firms that are covering the firm, MarketBeat Ratings reports. Two...
MarketBeat·25d ago
News Placeholder
Why Theravance Biopharma (TBPH) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·1mo ago
News Placeholder
mF International, Theravance Biopharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session
read more...
Benzinga·1mo ago
News Placeholder
Theravance Biopharma (NASDAQ:TBPH) Share Price Crosses Above Fifty Day Moving Average - What's Next?
Theravance Biopharma (NASDAQ:TBPH) Share Price Crosses Above Fifty Day Moving Average - Time to Sell...
MarketBeat·1mo ago
<
1
2
...
>

Latest TBPH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.